Compugen (CGEN) Income towards Parent Company (2009 - 2026)

Compugen (CGEN) reported Income towards Parent Company of $7.7 million for Q1 2026, up 7.59% on a YoY basis from $7.1 million in Q1 2025, and down 86.5% sequentially from $56.7 million in Q4 2025.

Compugen (CGEN) Income towards Parent Company (2009 - 2026) Analysis & Trends

Compugen (CGEN) has 18 years of Income towards Parent Company data on file, last reported at $7.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Income towards Parent Company rose 7.59% year-over-year to $7.7 million; the trailing twelve-month figure through Mar 2026 stood at $35.9 million (up 772.34% YoY), and the FY2025 full-year result was $35.3 million, up 348.35% from the prior year.
  • Income towards Parent Company fell to $7.7 million in Q1 2026, from $56.7 million in the prior quarter.
  • In the past five years, Income towards Parent Company ranged from a high of $56.7 million in Q4 2025 to a low of -$28.0 million in Q2 2023.
  • A 5-year average of $1.4 million and a median of -$3.1 million in 2022 frame the typical range for Income towards Parent Company.
  • Across the five-year window, Income towards Parent Company sank 198.03% in 2023 and jumped 1027.53% in 2025, its largest moves.
  • Tracing CGEN's Income towards Parent Company over 5 years: stood at -$3.1 million in 2022, then jumped by 414.13% to $9.7 million in 2023, then sank by 162.98% to -$6.1 million in 2024, then jumped by 1027.53% to $56.7 million in 2025, then plunged by 86.5% to $7.7 million in 2026.
  • Business Quant data shows CGEN's Income towards Parent Company at $7.7 million in Q1 2026, $56.7 million in Q4 2025, and -$6.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Compugen 215.59 Mn 123.84 Mn 352,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 7.66 Mn
Dec 31, 2025 56.74 Mn
Sep 30, 2025 -6.90 Mn
Jun 30, 2025 -21.61 Mn
Mar 31, 2025 7.12 Mn
Dec 31, 2024 -6.12 Mn
Sep 30, 2024 10.28 Mn
Jun 30, 2024 -16.62 Mn
Mar 31, 2024 7.26 Mn
Dec 31, 2023 9.71 Mn
Sep 30, 2023 -9.85 Mn
Jun 30, 2023 -28.00 Mn
Mar 31, 2023 9.31 Mn
Dec 31, 2022 -3.09 Mn
Sep 30, 2022 -11.75 Mn
Jun 30, 2022 28.56 Mn
Mar 31, 2022 -9.71 Mn
Dec 31, 2021 -8.65 Mn
Sep 30, 2021 -8.18 Mn
Jun 30, 2021 -9.50 Mn